Meta Seeks Legal Shield From Child-Harm Lawsuits Amid KOSA Talks 
John Jumper Leaves Google DeepMind for Anthropic Amid Intensifying AI Talent Race 
Apollo Debt Solutions Limits Redemptions as Withdrawal Requests Surge 
Google’s Open-Source AI Data Center Cooling Design Raises Commoditization Concerns 
SpaceX Stock Slides After IPO Rally as Valuation Concerns Grow 
Qualcomm Nears $4 Billion Acquisition of AI Chip Startup Modular 
Trump Says Anthropic No Longer Seen as National Security Threat 
California Drivers Sue BP, Walmart, 7-Eleven Over Alleged AI Gas Price Fixing 
JPMorgan Sees Strong Strategic Value in Potential AbbVie Acquisition of Apogee Therapeutics 
Hyundai to Acquire SoftBank’s Remaining Boston Dynamics Stake for $325 Million 
Frank Stronach Found Guilty of Sexual Assault and Indecent Assault in Ontario Court 
100+ Global Companies Push Governments to Prioritize Electrification for Economic Growth 
Obayashi to Acquire Multiplex in $526M Expansion Deal 
Qantas Unveils Wellness-Focused Nonstop Sydney-London Flights to Reduce Jet Lag 
SK Hynix Overtakes Samsung as South Korea’s Most Valuable Company 
BEDFORD, Mass., Jan. 27, 2016 -- ConforMIS, Inc. (NASDAQ:CFMS) announced today that it will host a conference call on Thursday, February 11, 2016, at 4:30 p.m. Eastern Time to discuss its financial results for the fourth quarter and fiscal year ended December 31, 2015. To participate in the conference call, please call 877-703-9876 (or 616-548-5612 for international) and use conference ID number 35700545.
The conference call will be hosted by Philipp Lang, MD, MBA, President and Chief Executive Officer, and Paul Weiner, Chief Financial Officer. The company will issue a news release announcing its fourth quarter and fiscal year 2015 financial results, and financial guidance for fiscal year 2016 on Thursday, February 11, 2016, prior to the conference call.
A live webcast of the conference call will also be available in the investor relations section of the company’s website at ir.conformis.com. The online archive of the webcast will be available on the company’s website for 30 days.
About ConforMIS, Inc.
ConforMIS is a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped, or customized, to fit each patient’s unique anatomy. ConforMIS offers a broad line of customized knee implants and pre-sterilized, single-use instruments delivered in a single package to the hospital. In recent clinical studies, ConforMIS iTotal CR demonstrated superior clinical outcomes, including better function and greater patient satisfaction, compared to traditional, off-the-shelf implants. ConforMIS owns or exclusively in-licenses approximately 500 issued patents and pending patent applications that cover customized implants and patient-specific instrumentation for all major joints.
For more information, visit www.conformis.com. To receive future releases in e-mail alerts, sign up at http://www.ir.conformis.com.
Contacts Investor Contact: Oksana Bradley [email protected] (781) 374-5598
